We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
STEMSOFT Software Inc. Licenses StemLab® Software to Cord Blood America
News

STEMSOFT Software Inc. Licenses StemLab® Software to Cord Blood America

STEMSOFT Software Inc. Licenses StemLab® Software to Cord Blood America
News

STEMSOFT Software Inc. Licenses StemLab® Software to Cord Blood America

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "STEMSOFT Software Inc. Licenses StemLab® Software to Cord Blood America"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

STEMSOFT Software Inc announces the licensing of StemLab to Cord Blood America’s cord banking laboratory in Las Vegas, NV.

“Our lab was looking for a proven solution that could manage all our product data electronically including the ability to generate complex outcome reports while providing a quick implementation,” said Dr. Geoffrey O’Neill, Laboratory Director for Cord Blood America.

“Cord Blood America has committed to utilize BioE’s PrepaCyteCB Cord Blood Processing System to enhance cell recovery and product safety. The PrepaCyte CB procedure template comes built into StemLab out of the box as a standard workflow. This unique turnkey solution provides our bank with BioE’s FDA 510(k) cleared system to use in processing our cords while also providing us with the ability to track and analyze all our data electronically with minimal configuration work required on our end.”  

StemLab is designed to manage and streamline the workflow followed in the cord blood laboratory. StemLab assists cell therapy and cord blood banking laboratories with heightening quality control, managing inventory and generating robust outcome reports including the ability to correlate product manufacture with clinical outcomes.

“We are very excited to work with Cord Blood America on this project and look forward to having them up and running with a fully electronic workflow shortly,” states Mario Laszczak, Operations Manager for STEMSOFT. StemLab also features built-in workflows for processing cords through RBC reduction and/or BioE’s PrepaCyte-CB processing system, as well as, templates for working with marrow and apheresis products.
Advertisement